Back
Mid-America Apartment Communities Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
46
MAA
Mid-America Apartment Communities
Last Price:
$152.73
Seasonality Move:
2.95%
Buy
56
ALNY
Alnylam Pharmaceuticals
Last Price:
$289.90
Seasonality Move:
21.07%
Sell
46
Mid-America Apartment Communities (MAA)
is a Sell
Is Mid-America Apartment Communities a Buy, Sell or Hold?
-
The current Mid-America Apartment Communities [MAA] share price is $152.76. The Score for MAA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MAA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $289.96. The Score for ALNY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MAA Stock Price Chart
What is Mid-America Apartment Communities's stock price today?
-
The Mid-America Apartment Communities share price today is $152.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAA is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $289.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MAA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 37.42 | Sell |
Chaikin Money Flow: | -317864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.88 - 163.94) | Sell |
Bollinger Bands (100): | (152.37 - 164.37) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.59 | Buy |
Relative Strength Index (14 RSI): | 62.95 | Buy |
Chaikin Money Flow: | 485655 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (248.28 - 283.98) | Buy |
Bollinger Bands (100): | (238.88 - 274.4) | Buy |
MAA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 158.42 | Sell |
20-day SMA: | 160.94 | Sell |
50-day SMA: | 160.4 | Sell |
200-day SMA: | 157.77 | Sell |
8-day EMA: | 157.57 | Sell |
20-day EMA: | 159.46 | Sell |
50-day EMA: | 159.87 | Sell |
200-day EMA: | 155.58 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 286.42 | Buy |
20-day SMA: | 272.38 | Buy |
50-day SMA: | 259.08 | Buy |
200-day SMA: | 261.27 | Buy |
8-day EMA: | 285.45 | Buy |
20-day EMA: | 274.14 | Buy |
50-day EMA: | 263.29 | Buy |
200-day EMA: | 249.32 | Buy |
Mid-America Apartment Communities Earnings Growth & MAA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.05 per share, a decrease this year of $2.26 per share, and a decrease next year of $0.32 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.03 per share, an increase next quarter of $1.64 per share, an increase this year of $1.16 per share, and an increase next year of $3.12 per share.
Mid-America Apartment Communities Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |